Verona Pharma PLC ADR (VRNA) — Financial Flexibility Index
Verona Pharma PLC ADR (VRNA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of $30.56 Million (operating CF $30.56 Million minus capex $0.00) represents 0% of total liabilities ($294.60 Million). Check Verona Pharma PLC ADR (VRNA) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verona Pharma PLC ADR Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for Verona Pharma PLC ADR across 20 annual periods. See Verona Pharma PLC ADR (VRNA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Verona Pharma PLC ADR (2005–2024)
Year-by-year free cash flow to debt coverage for Verona Pharma PLC ADR. For the full company profile including market capitalisation, see Verona Pharma PLC ADR market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | $-121.62 Million | $-122.20 Million | $269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | $-50.22 Million | $-50.22 Million | $58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | $-59.83 Million | $-59.86 Million | $29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | $-33.24 Million | $-33.25 Million | $38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | $-44.99 Million | $-45.08 Million | $19.35 Million | ▲ +21.9% |
| 2019 | -2.98x | $-43.97 Million | $-44.34 Million | $14.78 Million | ▼ -88.9% |
| 2018 | -1.58x | $-22.64 Million | $-22.98 Million | $14.37 Million | ▲ +26.0% |
| 2017 | -2.13x | $-27.68 Million | $-27.97 Million | $13.00 Million | ▼ -355.0% |
| 2016 | -0.47x | $-6.74 Million | $-6.89 Million | $14.40 Million | ▲ +86.3% |
| 2015 | -3.43x | $-9.20 Million | $-9.41 Million | $2.69 Million | ▲ +45.9% |
| 2014 | -6.33x | $-5.17 Million | $-5.51 Million | $816.08K | ▼ -59.1% |
| 2013 | -3.98x | $-3.21 Million | $-3.39 Million | $806.89K | ▲ +67.6% |
| 2012 | -12.30x | $-3.96 Million | $-4.08 Million | $322.11K | ▼ -24.1% |
| 2011 | -9.91x | $-2.40 Million | $-2.44 Million | $242.21K | ▼ -26.7% |
| 2010 | -7.82x | $-2.49 Million | $-2.56 Million | $317.94K | ▼ -40.7% |
| 2009 | -5.56x | $-2.58 Million | $-2.62 Million | $464.08K | ▲ +64.8% |
| 2008 | -15.81x | $-1.94 Million | $-1.98 Million | $123.01K | ▼ -108.9% |
| 2007 | -7.57x | $-2.36 Million | $-2.39 Million | $311.35K | ▼ -48.6% |
| 2006 | -5.09x | $-658.29K | $-687.68K | $129.31K | ▼ -3154.5% |
| 2005 | 0.17x | $3.44K | $3.44K | $20.65K | — |